Skip to main content


Media Coverage

CRISPR Patent Outcome Won’t Slow Innovation

13 December 2016
MIT Technology Review
Intellectual Property partner Colleen Tracy James (New York) was quoted in this article discussing the legal battle over who should own the rights to the century’s biggest biotechnology invention to date, a precise gene-editing system called CRISPR-Cas9.
The Build a Report feature requires the use of cookies to function properly. Cookies are small text files that are placed on your computer by websites that you visit. They are widely used in order to make websites work, or work more efficiently. If you do not accept cookies, this function will not work. For more information please see our Privacy Policy

You have no pages selected. Please select pages to email then resubmit.